Myriad Genetics, Inc. (Public, NASDAQ:MYGN)
Myriad Genetics Announces First Quarter Fiscal 2007 Financial Results Conference Call SALT LAKE CITY Myriad Genetics, Inc. (NASDAQ:MYGN) has arranged a conference call with the management team to provide a company update. Peter Meldrum, President and Chief Executive Officer will host the call along with Jay Moyes, Chief Financial Officer, Gregory Critchfield, M.D., President of Myriad Genetic Laboratories, Inc. and Adrian Hobden, Ph.D., President of Myriad Pharmaceuticals, Inc. DATE: November 7, 2006 TIME: 10:00 am ET DOMESTIC DIAL-IN: (888) 589-2820 INTERNATIONAL DIAL-IN: (706) 634-2173 CONFERENCE ID# 9681049 (Please dial in approximately 10 minutes before the call is scheduled to begin) A press release will be issued at 6:30 am ET on November 7, 2006. Replay of the call will be available from two hours after the call through November 14th by dialing (800) 642-1687 or (706) 645-9291, and entering conference ID number 9681049. A live audio Webcast will be available at: www.myriad.com http://tech.groups.yahoo.com/group/biotech-news/ http://www.arizonabiotech.com/ http://www.azhttp.com/ http://www.arizonabiotech.com/ http://groups.yahoo.com/group/biotech-news/ http://www.arizonaentrepreneurs.com/ http://www.azhttp.com/ Yahoo! Groups Links <*> To visit your group on the web, go to: http://groups.yahoo.com/group/biotech-news/ <*> Your email settings: Individual Email | Traditional <*> To change settings online go to: http://groups.yahoo.com/group/biotech-news/join (Yahoo! ID required) <*> To change settings via email: mailto:[EMAIL PROTECTED] mailto:[EMAIL PROTECTED] <*> To unsubscribe from this group, send an email to: [EMAIL PROTECTED] <*> Your use of Yahoo! Groups is subject to: http://docs.yahoo.com/info/terms/
